Search Results - "Shin, Bo H"

An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer by To, Ciric, Beyett, Tyler S, Jang, Jaebong, Feng, William W, Bahcall, Magda, Haikala, Heidi M, Shin, Bo H, Heppner, David E, Rana, Jaimin K, Leeper, Brittaney A, Soroko, Kara M, Poitras, Michael J, Gokhale, Prafulla C, Kobayashi, Yoshihisa, Wahid, Kamal, Kurppa, Kari J, Gero, Thomas W, Cameron, Michael D, Ogino, Atsuko, Mushajiang, Mierzhati, Xu, Chunxiao, Zhang, Yanxi, Scott, David A, Eck, Michael J, Gray, Nathanael S, Jänne, Pasi A

“…Epidermal growth factor receptor (EGFR) therapy using small-molecule tyrosine kinase inhibitors (TKIs) is initially efficacious in patients with EGFR-mutant…”
Get full text

Allosteric inhibition of drug resistant forms of EGFR L858R mutant NSCLC by To, Ciric, Beyett, Tyler S., Jang, Jaebong, Feng, William W., Bahcall, Magda, Haikala, Heidi M., Shin, Bo H., Heppner, David E., Rana, Jaimin K., Leeper, Brittaney A., Soroko, Kara M., Poitras, Michael J., Gokhale, Prafulla C., Kobayashi, Yoshihisa, Wahid, Kamal, Kurppa, Kari J., Gero, Thomas W., Cameron, Michael D., Ogino, Atsuko, Mushajiang, Mierzhati, Xu, Chunxiao, Zhang, Yanxi, Scott, David A., Eck, Michael J., Gray, Nathanael S., Jänne, Pasi A.

“…Although treatment with small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is initially efficacious for patients with…”
Get full text